If you are wondering whether ServiceNow is starting to look like a deal or still priced for perfection, you are not alone. This stock sits at the crossroads of high expectations and shifting market ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--ServiceNow (NYSE: NOW), the AI control tower for business reinvention, today announced it has completed its acquisition of Moveworks. The acquisition advances ...

Bloomberg reported ServiceNow is eying a $7 billion cybersecurity acquisition. A Wall Street analyst also downgraded shares due to the disruptive potential of generative AI. The dual bits of news led ...

ServiceNow Inc. is in advanced talks to buy the cybersecurity startup Armis in a deal that may be valued at as much as $7 billion and would represent the tech company’s largest acquisition to date. A ...

A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...

ServiceNow Inc. Annual cash flow by MarketWatch. View NOW net cash flow, operating cash flow, operating expenses and cash dividends.

AI companies say state laws hinder development Trump says single rule will help US compete Bipartisan opposition is expected from the states Dec 8 (Reuters) - U.S. President Donald Trump said on ...

Marketers, bloggers, and small business owners have been struggling with the same problem for years: how to create compelling content. Why is it such a struggle? Because they're using the wrong ...

Flowchart vs. process map, what do you choose to use? When it comes to mapping out a project, you’ve got several choices on how to visualize them. If you’ve had trouble deciding on a format for your ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...